Table 1.
Characterization of the cohort of 193 prostate cancer samples
| Characteristics | n(%) |
|---|---|
|
Age (years) |
|
| < 50 |
11 (5.69) |
| 50 - 70 |
160 (82.9) |
| >70 |
21 (11.4) |
|
Preoperative PSA (ng/ml) |
|
| < 10 |
114 (60.6) |
| 10 ≥ PSA < 20 |
50 (26.5) |
| ≥ 20 |
24 (12.9) |
|
TNM stage (pathologic) |
|
| II |
95 (49.2) |
| III |
86 (44.6) |
| IV |
8 (6.23) |
|
Gleason score |
|
| 6 (3 + 3) |
102 (52.8) |
| 7 (3 + 4) |
46 (23.8) |
| 7 (4 + 3) |
19 (9.8) |
| 8 - 10 |
26 (13.5) |
|
Angiolymphatic invasion |
|
| Presence |
44 (23.2) |
| Absence |
146 (76.9) |
|
Extraprostatic extension |
|
| Presence |
41 (21.7) |
| Absence |
148 (78.3) |
|
Positive margin |
|
| Presence |
68 (21.6) |
| Absence |
122 (78.4) |
|
Seminal vesicle invasion |
|
| Presence |
22 (11.6) |
| Absence |
168 (88.4) |
|
Positive lymph node |
|
| Presence |
10 (5.44) |
| Absence |
174 (94.6) |
|
Biochemical recurrence |
|
| Presence |
115 (60.5) |
| Absence | 75 (39.5) |